Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development
Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin
Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin
View: Text | PDF
Research Article Development Inflammation Pulmonology

Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development

  • Text
  • PDF
Abstract

Fibroblasts in the lung mesenchyme produce growth factors and extracellular matrix components that guide formation of distal airspaces during the saccular stage of lung development. Inflammation in preterm infants disrupts this process, leading to bronchopulmonary dysplasia (BPD). To examine how mesenchymal inflammation contributes to BPD pathogenesis, we developed a transgenic mouse model (IKKβTbx4) in which expression of activated human IκB kinase β (IKKβ), an upstream activator of NF-κB, was induced in Tbx4 lung enhancer–positive mesenchymal cells during the saccular stage of lung development (P0–P5). Saccular-stage IKKβTbx4 mice exhibited a BPD-like phenotype with interstitial thickening and reduced distal airspaces at P5, progressing to emphysematous enlargement of the distal lung at 2 months of age. Mesenchymal NF-κB activity upregulated the chemokines CCL2 and CCL7, recruiting CCR2pos monocyte-derived macrophages to the lung. Recruited macrophages disrupted the elastin scaffold and impaired microvascular organization with reductions in CAP2 endothelial cells and pericytes. Blocking CCR2-dependent monocyte recruitment with a small-molecule CCR2 antagonist rescued the abnormal lung phenotype. These findings identify mesenchyme-macrophage crosstalk as a mechanism by which inflammation disrupts saccular-stage lung development, suggesting a role for this signaling axis in BPD pathogenesis.

Authors

Benjamin C. Crawford, Jessica Chauviere Lee, Bertha C. Elias, Shivangi Dave, Riet van der Meer, Wei Han, Alexandria L. Sharkey, David S. Nichols, Charles Shissias, Lauren Pate, Hayden Tan, Dawn C. Newcomb, Wei Shi, Lawrence S. Prince, Erin J. Plosa, Bradley W. Richmond, Timothy S. Blackwell, Susan H. Guttentag, John T. Benjamin

×

Figure 4

Inhibiting recruitment of CCR2pos monocyte-derived macrophages rescues structural abnormalities in IKKβTbx4 lungs.

Options: View larger image (or click on image) Download as PowerPoint
Inhibiting recruitment of CCR2pos monocyte-derived macrophages rescues s...
(A) Schematic of experimental time points. For these experiments, doxycycline was added to drinking water of lactating dams from P1 to P5, and i.p. injections of either vehicle (DMSO, 20 μL) or CCR2 antagonist (RS504393, 2 μg/g) were administered daily from P1 to P4. Lungs were harvested on P5. (B) Flow cytometry was used to quantify viable CCR2pos monocytes and macrophages in lungs of vehicle- or RS504393-treated littermate control (CTRL) and IKKβTbx4 mice at P5. (C) Representative H&E-stained lung sections from vehicle- and RS504393-treated mice at P5. (D) Morphometric quantification of airspace volume density (ASVD) of vehicle- and RS504393-treated mouse lungs at P5. Data are expressed as mean ± SEM. n = 10 to 12 nonoverlapping lung fields per lung (biological replicate) (D), n = 5 to 17 mice per group (B); n = 4 to 8 mice per group (D); scale bar: 100 μm (C); *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by 1-way ANOVA with Tukey’s multiple-comparison test (B and D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts